These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1232 related articles for article (PubMed ID: 2932884)

  • 1. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired cell-mediated immunodepression in acute Chagas' disease.
    Teixeira AR; Teixeira G; Macêdo V; Prata A
    J Clin Invest; 1978 Dec; 62(6):1132-41. PubMed ID: 107195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity.
    Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A
    Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL
    Acta Cient Venez; 1992; 43(6):330-40. PubMed ID: 1343745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease.
    Grögl M; Kuhn RE
    J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection.
    García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM
    Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trypanosoma cruzi: infection of T lymphocytes and their destruction by antibody-dependent cell-mediated cytotoxicity.
    Velge P; Kusnierz JP; Ouaissi A; Marty B; Pham BN; Capron A
    Eur J Immunol; 1991 Sep; 21(9):2145-52. PubMed ID: 1909643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: immunological consequences of parasite modification of host cells.
    Ribeiro Dos Santos R; Hudson L
    Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human humoral immunity to hsp70 during Trypanosoma cruzi infection.
    Engman DM; Dragon EA; Donelson JE
    J Immunol; 1990 May; 144(10):3987-91. PubMed ID: 2110215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of anti-acetylcholinesterase and anti-idiotype antibodies in human and experimental Chagas' disease: pathological implications.
    Ouaissi A; Cornette J; Velge P; Capron A
    Eur J Immunol; 1988 Dec; 18(12):1889-94. PubMed ID: 3146509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas' disease: trends in immunological research and prospects for immunoprophylaxis.
    Teixeira AR
    Bull World Health Organ; 1979; 57(5):697-710. PubMed ID: 120233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins.
    Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W
    J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytophilic antibody in experimental Chagas' disease.
    Kuhn RE; Cassida GW
    J Parasitol; 1981 Dec; 67(6):807-12. PubMed ID: 6799634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of anti-Trypanosoma cruzi antibody isotype specificities by western blot in sera from patients with different forms of Chagas' disease.
    Morgan J; Colley DG; Pinto Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Powell MR
    J Parasitol; 1998 Jun; 84(3):641-3. PubMed ID: 9645878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
    Zúñiga E; Montes C; Barbieri G; Gruppi A
    Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotype determination of anti-Trypanosoma cruzi antibody in murine Chagas' disease.
    Rowland EC; Mikhail KS; McCormick TS
    J Parasitol; 1992 Jun; 78(3):557-61. PubMed ID: 1375959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.